arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Septerna, Inc.

SEPN
$47.44 ▼ -0.44 (-0.92%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
4 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Bearish
auto_awesome

Analytical Summary

Septerna, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.1B
Dividend Yield —
Revenue Growth 4174.5% ↗
Op. Margin -148.6%
ROIC -17.9% ↗
FCF / Share $2.48 ↗
Trailing P/E —
Price / Book 5.6x
FCF Yield 5.2%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

4-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$45.95M
↑ +4174.5% —
Net Income Profit after all expenses
$-48.88M
↑ +31.9% —
FCF / Share Free cash flow per share
$2.48
↑ +135.2% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
35
Returns ↓
32
Cash Quality ↑
6

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 4 years · 15 quarters